Catalyst Wire Dossier Catalyst Wire Dossier

Sandostatin

Octreotide acetate · Novartis Pharmaceuticals Corporation
Drug timelines are a Plus or Pro feature.

36 regulatory and trial events tracked for Sandostatin, covering 2007-03-01 to 2025-12-22. Get the full timeline:

Most recent: Clinical Trial Update: Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA) [Phase 4]

See pricing